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The Human Secreted Group IIA Phospholipase A2 (hsPLA2GIIA) presents potent bactericidal activity, and
is considered to contribute to the acute-phase immune response. Hydrolysis of inner membrane phos-
pholipids is suggested to underlie the bactericidal activity, and we have evaluated this proposal by
comparing catalytic activity with bactericidal and liposome membrane damaging effects of the G30S,
H48Q and D49K hsPLA2GIIA mutants. All mutants showed severely impaired hydrolytic activities against
mixed DOPC:DOPG liposome membranes, however the bactericidal effect against Micrococcus luteus was
less affected, with 50% killing at concentrations of 1, 3, 7 and 9 mg/mL for the wild-type, D49K, H48Q and
G30S mutants respectively. Furthermore, all proteins showed Ca2þ-independent damaging activity
against liposome membranes demonstrating that in addition to the hydrolysis-dependent membrane
damage, the hsPLA2GIIA presents a mechanism for permeabilization of phospholipid bilayers that is
independent of catalytic activity, which may play a role in the bactericidal function of the protein
 2011 Elsevier Masson SAS. Open access under the Elsevier OA license.1. Introduction
Phospholipases A2 (PLA2, EC 3.1.1.4) are involved in a range of
functional roles involving the release of lipid mediators and
membrane remodeling. The PLA2 superfamily currently recognizes
15 groups, and a total of 22 PLA2 isoforms and PLA2-like domains
have been identiﬁed from sequence analysis of the human genome
[1]. These include representatives of PLA2Groups I, II, III, IV, V, VI, VII,
X and XII, and ongoing efforts are focused on the biochemical char-
acterization and physiological functions of these enzymes. The
human secreted Group II PLA2s (hsPLA2GII) include IIA, IIC, IID, IIE,
and IIF, of which sPLA2-IIC is likely to be a pseudogene [2], and with
the exception of hsPLA2GIIA the biological functions of the remaining
proteins remain to be clearly deﬁned. The hsPLA2GIIA is widely
regarded as a pro-inﬂammatory factor [3,4], a view supported by
recent gene knockout data from mice [5], and altered levels of the
sPLA2-GIIA are observed in many pathological situations including
cancer [6], respiratory allergy [7] and apoptosis [8]. Physiological
roles of the hsPLA2GIIA include a potent bactericidal activity
primarily against Gram-positive bacteria, which has been suggestedica, Faculdade de Filosoﬁa,
São Paulo, Avenida Bandeir-
reto-SP, Brazil. Tel.: þ55 016
nder the Elsevier OA license.to be due to the ability of the protein to traverse the bacterial cellwall
and cause the hydrolysis of plasma membrane phospholipids
resulting in the loss of bilayer integrity and cell death [9e11].
All PLA2s catalyze the hydrolysis the sn-2 acyl bonds of sn-3
glycerophospholipids [12], and the catalytic cycle of Group I/II/V
PLA2s involves activation of a conserved water molecule in the
active site by the H48/D99 pair, followed by nucleophilic attack on
the sn-2 position of the phospholipid to form a tetrahedral reaction
intermediate. The Ca2þ ion cofactor binds to the D49 carboxyl
group andmain chain carbonyl oxygens of the calcium binding loop
residues 28e33, and is essential both for stabilization of the
tetrahedral intermediate and completion of the reaction cycle to
form the fatty acid and lysophospholipid products [13,14]. Previous
studies have demonstrated that site directed mutagenesis of the
active site residues H48 and D49 results in a drastic reduction
[15,16] or even loss of catalytic function in Group I/II PLA2s [17,18].
The lack of hydrolytic activity in the Group II Lys49-PLA2 variants
isolated from the venoms of viperid snakes is the result of both the
D49K substitution and mutations in the calcium binding loop
region [19,20]. Despite their lack of hydrolytic activity, the Lys49-
PLA2s nevertheless present potent bactericidal effects [21,22],
demonstrating that catalytic hydrolysis of membrane lipids is not
obligatory for manifestation of the bactericidal effect. This has
prompted us to evaluate the bactericidal effects of active site
mutants of the hsPLA2GIIA in which hydrolytic activity has been
severely reduced or effectively abolished.
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2.1. Sub-cloning and construction of the expression vector for
hsPLA2GIIA
A full-length cDNA encoding hsPLA2GIIA (GenBank BC 005919)
in vector pDNR-lib was from the I.M.A.G.E Consortium/LNNL
(http://image.llnl.gov/, clone ID 4274550). The codons encoding
G35 and S36 (50-GGA TCC-30) form a BamHI restriction site, which
was eliminated by silent site directed mutagenesis (50-GGA TCT-30,
base change in italics) in order to facilitate subsequent cloning
steps. The protein-coding region was ampliﬁed using forward (50-
CAGGCCCATATGGCTTTGGTGAAT-30) and reverse (50-TTTCCAGG-
GATCCGGGGACTC-30) primers that introduced restriction sites for
NdeI and BamHI (nucleotides underlined) at the 50 and 30 extrem-
ities respectively. The forward primer introduced themutation N1A
(nucleotides in italics in the primer sequence), which increases the
efﬁciency of post-translation methionine cleavage by N-terminal
methionine peptidase, without altering the catalytic properties of
the enzyme [23]. After digestion with NdeI and BamHI, the ampli-
ﬁed fragment was cloned into the equivalent sites of expression
vector pET-3a, and nucleotide sequencing conﬁrmed the expected
construct.
Site directed mutagenesis of the hsPLA2GIIA by PCR mutagen-
esis [24] was used to introduce the single mutations G30S (oligo-
nucleotide 50-GCCACCCACGCTACAGTGGC-30 e base changes
underlined), H48Q (50-AGCAACAGTCTTGAGTGACACA-30) and D49K
(50-GTAGCAACATTTATGAGTGACACA-30). The mutated protein-
coding regions were subcloned into the expression vector pET-3a,
and all constructs were fully sequenced to conﬁrm the expected
base changes.
2.2. Expression of hsPLA2GIIA as inclusion bodies in E. coli
The hsPLA2GIIA and mutants were expressed in Escherichia coli
strain BL21(DE3)[pLysS] in the form of inclusion bodies, and the
solubilization, refolding and puriﬁcation of the recombinant
hsPLA2GIIA were described previously [25]. The secondary struc-
ture of all samples was routinely checked by far ultraviolet circular
dichroism, and protein concentration was quantiﬁed by comparing
the measured ellipticity at 222 nmwith a standard curve prepared
using known quantities of the hsPLA2GIIA.
2.3. Far ultraviolet circular dichroism (far-UVCD) of recombinant
hsPLA2GIIA
The far-UVCD spectra of the hsPLA2GIIA and mutants were
collected at a concentration of 1.1 mg mL1 in 20 mM HEPES buffer
(pH 7.0) with a Jasco 810 spectropolarimeter (JASCO Corporation,
Tokyo, Japan) over wavelengths of 185e250 nm, using 100 mm path
length quartz cuvettes and a 4 nm bandwidth at a constant
temperature of 298 K. The accumulated average of six protein
spectrawas corrected by subtraction of the spectra of the equivalent
buffer in the absence of protein.
2.4. Phospholipase A2 hydrolytic activity assay
The hydrolytic activity of the hsPLA2GIIA and mutants was
quantiﬁed by measuring fatty acid binding to intestinal fatty acid
binding protein conjugated with the ﬂuorescent probe acrylodan
(ADIFAB - Invitrogen-Molecular Probes, [26]). Unilamellar lipo-
somes composed of either a 9:1 or a 1:1 molar ratio of dioleoyl
phosphatidylcholine (DOPC e Sigma-Aldrich, St. Louis, MO, USA)
anddioleoyl phosphatidylglycerol (DOPGe Sigma-Aldrich, St. Louis,
MO,USA)werepreparedby reverse phase evaporation, andmixed ataﬁnal concentration of 30 mg/mLwith 3 mg/mL of ADIFAB in reaction
buffer (20 mM Hepes, 20 mM NaCl, 1 mM CaCl2). Wild-type
(0.1 mg mL1) or mutant (30 mg mL1) hsPLA2GIIA was added to
the liposome/ADIFABmixture, and the ﬂuorescence emission at 505
and 425 nmwasmeasuredwith an excitationwavelength of 385 nm
for 30min using a Spectronic 8100C spectroﬂuorometer (Spectronic
Instruments, Urbana, IL). The speciﬁc activity of the enzyme was
determined from analysis of the 505 nm/425 nm signal ratio as
previously described [25,26].
2.5. Bactericidal activity by counting colony forming units (CFU)
The bactericidal effect of hsPLA2GIIA and mutants over the
concentration range of 0e32 mg/mL was evaluated against the
Gram-positive bacteria Micrococcus luteus (ATCC 9341) as previ-
ously described [25].
2.6. Release of entrapped ﬂuorescent markers from liposomes
Membrane damaging activity was evaluated by the release of
the entrapped self-quenching ﬂuorescent dye calcein from lipo-
somes composed of either 1:1 or 9:1 molar ratio DOPC:DOPG.
Calcein loaded liposomes were prepared as previously described
[27], and proteins (ﬁnal concentration 4 mg mL1) and liposomes
were mixed to a protein:lipid molar ratio of 1:200. Kinetics of
membrane damage weremonitored by the increase in ﬂuorescence
emission at 520 nm with excitation at 490 nm using a Spectronic
8100C spectroﬂuorometer (Spectronic Instruments, Urbana, IL),
and the signal after 140 s exposure to the proteins was expressed as
the percentage of total calcein liberation on addition of 5% Triton X-
100. Statistical analyses were performed with one-way ANOVA
followed by the Tukey comparison test using Origin software
(OriginLab, Northampton, MA, USA). A P value of less than 0.05 was
considered as statistically signiﬁcant.
3. Results
3.1. Site directed mutants in the active site region retain native-like
structure
The solubilization and refolding of recombinant hsPLA2GIIA in
the presence of a gel ﬁltration matrix has been previously used to
successfully refold the Lys49-PLA2 bothropstoxin-I [28] and the
human secreted group IID PLA2s (hsPLA2GIID [29]). Fig. 1 presents
the far-UVCD spectra of the wild-type hsPLA2GIIA and active site
mutants G30S, H48Q and D49K. All spectra demonstrate minima at
209 and 222 nm, and amaximum at 194 nm, typical of proteins rich
in a-helices and are consistent with the secondary structure
content of the wild-type protein as predicted from the crystal
structure [30]. The spectral proﬁles suggest that the secondary
structure of the protein was not signiﬁcantly inﬂuenced by muta-
genesis in the active site region, which is in accord with crystal
structures of the H48Q mutant of hsPLA2GIIA [31] and active site
mutants of bovine pancreatic PLA2 [32] where the structural
perturbations were limited to the immediate amino-acid neighbors
of the mutated residues.
3.2. Catalytic activity is drastically reduced in the active site
mutants
The hydrolytic activities of the wild-type hsPLA2GIIA and active
site mutants against DOPC:DOPG liposome membranes are pre-
sented in Fig. 2. Under these conditions the speciﬁc activity of the
wild-type protein is 274 mmolmin1mg1,which is similar to values
previously reported against liposome membranes composed of
Fig. 1. FarUV CD spectra of wild-type hsPLA2GIIA and mutants. The spectra are from
the wild-type (solid line), and the active site mutants G30S (dashed line), H48Q (dotted
line) and D49K (dashed-dotted line). See the materials and methods section for further
details.
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mutants G30S, H48Q and D49K demonstrate a drastic reduction in
catalytic activity, showing 0.02% (for the D49K mutant) and 0.04%
(for the G30S and H48Q mutants) of the wild-type activity. No
activity was observed in control experiments performed in the
presence of EGTA (data not shown), demonstrating that the residual
activity of the mutants is dependent on the calcium cofactor. These
results conﬁrm previously reports that the H48Q mutants of the
hsPLA2GIIA retain low levels of catalytic activity [15,31].
3.3. Bactericidal and catalytic activities are not correlated
It has been previously suggested that the bactericidal activity of
the hsPLA2GIIA is the consequence of the hydrolysis of plasma
membrane phospholipids, which leads to loss of bilayer integrity
and cell death [10,34]. The relation between hydrolytic activity andFig. 2. Hydrolytic activity of the hsPLA2GIIA and mutants against liposome
membranes composed of an equimolar mixture of DOPC and DOPG as estimated by
fatty acid release detected using ADIFAB. See materials and methods for further details.the killing effect of the protein was evaluated, and Fig. 3 presents
the bactericidal effect of the hsPLA2GIIA and mutants against the
Gram-positive bacterium M. luteus. The wild-type protein causes
a 50% reduction in the CFU at a concentration of approximately
1 mg/mL. The corresponding concentrations for the active site
mutants are 3 mg/mL (H48Q), 7 mg/mL (D49K) and 9 mg/mL (G30S).
These results demonstrate that although the active site mutants
show severely reduced hydrolysis they nevertheless retain signiﬁ-
cant bactericidal activity. It is possible that the residual activity of
the active site mutants may be sufﬁcient to cause the observed
bactericidal effects, however it has previously been demonstrated
that M. luteus has a robust response to the hydrolytic challenge
imposed by treatment with the hsPLA2GIIA, where hydrolysis of up
to 50% of the plasma membrane phospholipids has no lethal effects
[35]. Furthermore, our results demonstrate that the levels of
activity of the active site mutants will not result in the signiﬁcant
levels of hydrolysis of the plasma membrane phospholipids that
were observed with the native enzyme. This suggests that the
bactericidal effect of the hsPLA2GIIA is only partly dependent on
the hydrolytic function, which in turn indicates that hydrolysis-
independent effects may be important for manifestation of the
bactericidal activity of the hsPLA2GIIA.3.4. Liposome membrane disruption of hsPLA2GIIA and mutants is
Ca2þ-independent
The Ca2þ-independent membrane permeabilization of liposome
membranes by hsPLA2GIIA was measured by the release of an
entrapped self-quenching dye, where loss of liposome membrane
integrity results in dilution of the ﬂuorophore with a consequent
increase in the ﬂuorescence signal [27,36]. Fig. 4 shows the release
of entrapped calcein from liposomes composed of 10% and 50%
negatively charged phospholipids after exposure to the wild-type
hsPLA2GIIA and mutants in the absence of Ca2þ. In Fig. 4A, the
release of calcein from liposomes composed of a 9:1 molar ratio of
DOPC:DOPG is between 15% and 20% of the total encapsulated
marker. In comparison, Fig. 4B shows the release of 40e55%
entrapped marker from liposomes composed of an equimolar
mixture of the same phospholipids. The bacterial inner membrane
is rich in negatively charged phospholipids, and these results
indicate that such membranes are susceptible to efﬁcientFig. 3. Bactericidal effect of the hsPLA2GIIA and mutants. The bactericidal effect was
measured against Micrococcus luteus by the reduction in the number of colony forming
units (CFU) with the wild-type protein (closed squares), and the active site mutants
G30S (open squares), H48Q (solid triangles) and D49K (open triangles). See materials
and methods for further experimental details.
Fig. 4. Calcium independent membrane damaging activity of the hsPLA2GIIA and mutants. Release of the ﬂuorescent marker calcein was measured from liposomes comprised of
DOPC and DOPG in 9:1 (A) or 1:1 (B) molar ratios. Figures present the mean þ/ standard deviation (n ¼ 3) for independent marker release experiments with the wild-type and
mutant proteins against liposomes composed of 9:1 (A) or a 1:1 (B) molar ratios of DOPC:DOPG. All experiments were performed using a protein concentration of 4 mg/mL and
a protein:lipid molar ratio of 1:200.
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membranes composed of both 10% and 50% negatively charged
phospholipids is observed in the absence of the Ca2þ-cofactor,
demonstrating that the membrane permeabilization effect is
independent of hydrolytic activity. Furthermore, the levels of
membrane damaging activity of the H48Q and D49K mutants are
similar to those observed for the wild-type protein, and in the case
of activity against 50% negatively charged membranes, the G30S
shows an increased activity in relation to the wild-type protein
(P < 0.05). These results clearly indicate that mutagenesis of key
residues in the active site region do not impair the Ca2þ-indepen-
dentmembrane damaging activity of the protein. These results may
be compared with the recent demonstration that both the
hsPLA2GV and hsPLA2GIIF provoke rapid Ca2þ-independent
membrane permeabilization against liposome membranes [36],
and where the H47Q mutant of the hsPLA2GIIF (analogous to the
H48Q in the PLA2GIIA) maintains the same level of activity as the
wild-type protein [36].
4. Discussion
The interfacial recognition site [37] or i-face [38] is a conserved
structural feature in all group I/II PLA2s, and is comprised of a ring
of polar and charged residues surrounding the hydrophobic
substrate binding cleft and the active site, resulting in a high afﬁnity
of the hsPLA2GIIA for anionic membranes [39,40]. It has been
proposed that the bactericidal activity of hsPLA2GIIA against
M. luteus results from the hydrolysis of anionic phospholipids in the
bacterial plasma membrane, an event that is possible only after
penetration of the cell wall of the bacteria by the protein [10,34].
Passage of the hsPLA2GIIA through the bacterial cell wall was
suggested to involve the continuous formation and breaking of
multiple electrostatic interactions between cationic amino-acid
side-chains and anionic cell wall components [9,34], and thismodel
has been used to explain the reduced bactericidal effects of charge
reversal mutants of the protein [9,41].
This model of hsPLA2GIIA bactericidal activity emphases the
membrane damage due to phospholipid hydrolysis. However,
hydrolysis-independent bactericidal effects are observed in the
Group II Lys49-PLA2s from the venoms of viperid snakes [21,22].
The current knowledge as to the killing mechanism of these cata-
lytically inactive Lys49-PLA2s against Gram-negative bacteria
shares several features with the proposed mechanism for the
hsPLA2GIIA. Using recombinant bothropstoxin-I, a Lys49-PLA2
from the venom of Bothrops jararacussu, it was demonstrated that
protein is able to cross the bacterial cell wall and disrupt theintegrity of the phospholipids in the plasma membrane [21].
Furthermore, alterations in the permeabilization of the bacterial
plasma membrane by Lys49-PLA2 mutants have been shown to
correlate well with the membrane destabilizing effect against
liposome membranes composed of anionic phospholipids [21].
These results have led to the suggestion that the permeabilization
of the bacterial plasma membrane and liposome phospholipids
bilayers by the Lys49-PLA2s occurs by a related Ca2þ-independent
mechanism of action. A “micelle nucleation” model for this activity
has been proposed [42,43], whereupon association with the target
membrane a sufﬁcient number of phospholipids bind to the IRS of
the protein to form a pre-micelle PLA2/phospholipid complex. This
complex dissociates from the membrane thereby removing phos-
pholipids and resulting in the loss of bilayer integrity. Given that
both the Lys49-PLA2s and the hsPLA2GIIA present a high pI and
have interfacial recognition sites that are rich in cationic residues, it
is reasonable to propose a conserved Ca2þ-independent membrane
damaging mechanism for both the Lys49-PLA2 and the PLA2GIIA.
A Ca2þ-independent function for hsPLA2GIIA has recently been
described in cultured THP-1 cells differentiated to a macrophage-
like cell phenotype, where the protein is involved in the transport
of extracellular anionic amphiphiles (presumed to be cell debris) to
the cell nuclei [44]. It is proposed that these anionic amphiphiles
are transported in the form of a complex with the protein [44],
which shares striking similarity with the idea of accumulation of
amphiphilic molecules at the IRS of the protein by a micelle
nucleation mechanism.
Data is accumulating which therefore indicates that physio-
logical functions of the hsPLA2GIIA may be independent of
hydrolytic activity, and here we have presented evidence indi-
cating that bacterial killing by the protein is the result of
hydrolysis-dependent and hydrolysis-independent mechanisms
acting in conjunction. Bactericidal effects due to the perturbation
of the bacterial plasma membrane by non-hydrolytic mechanisms
are well established for cationic antibiotic peptides [45], and the
results presented here suggest that non-hydrolytic mechanisms
may also be relevant for the activity of the hsPLA2GIIA. Further
studies are needed to evaluate the physiological relevance of this
Ca2þ-independent mechanism both in the hsPLA2GIIA and in other
PLA2s with a high density of cationic residues in their interface
recognition sites.
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